EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride

C2 Pharma receives the European Directorate for the Quality of Medicines and Healthcare second Certificate of Suitability for Cyclopentolate Hydrochloride, a significant achievement for our dedicated team. 

The #cep approved by the EDQM is the second existing approval for Cyclopentolate Hydrochloride and the only approval allowing our #gmp-certified manufacturing site to supply to other markets.